Darryl C. De Vivo

29.4k total citations · 5 hit papers
294 papers, 14.8k citations indexed

About

Darryl C. De Vivo is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Darryl C. De Vivo has authored 294 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Molecular Biology, 113 papers in Genetics and 107 papers in Clinical Biochemistry. Recurrent topics in Darryl C. De Vivo's work include Neurogenetic and Muscular Disorders Research (110 papers), Metabolism and Genetic Disorders (106 papers) and Mitochondrial Function and Pathology (68 papers). Darryl C. De Vivo is often cited by papers focused on Neurogenetic and Muscular Disorders Research (110 papers), Metabolism and Genetic Disorders (106 papers) and Mitochondrial Function and Pathology (68 papers). Darryl C. De Vivo collaborates with scholars based in United States, Italy and United Kingdom. Darryl C. De Vivo's co-authors include Kristin Engelstad, Salvatore DiMauro, Jacqueline Montes, Steven G. Pavlakis, Dong Wang, Claudia A. Chiriboga, Lewis P. Rowland, Peter C. Phillips∥, Veronica J. Hinton and Basil T. Darras and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Darryl C. De Vivo

285 papers receiving 14.4k citations

Hit Papers

Mitochondrial myopathy, encephalopathy, lactic acidosis, ... 1984 2026 1998 2012 1984 2016 1991 2015 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome
    1984 888 citations Salvatore DiMauro, Darryl C. De Vivo et al. profile →
  2. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
    2016 736 citations Richard S. Finkel, Claudia A. Chiriboga et al. profile →
  3. Defective Glucose Transport across the Blood-Brain Barrier as a Cause of Persistent Hypoglycorrhachia, Seizures, and Developmental Delay
    1991 523 citations Darryl C. De Vivo et al. profile →
  4. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
    2015 516 citations Darryl C. De Vivo et al. profile →
  5. Results from a phase 1 study of nusinersen (ISIS-SMN Rx ) in children with spinal muscular atrophy
    2016 460 citations Claudia A. Chiriboga, Basil T. Darras et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darryl C. De Vivo United States 66 8.3k 4.9k 3.8k 3.6k 2.3k 294 14.8k
Lewis P. Rowland United States 67 8.1k 1.0× 3.3k 0.7× 2.8k 0.7× 2.0k 0.6× 1.6k 0.7× 261 18.2k
Anders Oldfors Sweden 55 10.4k 1.2× 3.7k 0.7× 1.0k 0.3× 1.9k 0.5× 650 0.3× 286 13.7k
Michio Hirano United States 82 16.4k 2.0× 7.8k 1.6× 628 0.2× 1.6k 0.4× 638 0.3× 341 20.5k
Filippo M. Santorelli Italy 57 8.1k 1.0× 3.0k 0.6× 972 0.3× 1.2k 0.3× 409 0.2× 526 12.5k
S. DiMauro United States 72 12.7k 1.5× 8.0k 1.6× 454 0.1× 1.5k 0.4× 502 0.2× 237 15.9k
Gabriele Siciliano Italy 52 4.6k 0.6× 903 0.2× 872 0.2× 2.2k 0.6× 451 0.2× 429 10.1k
Serenella Servidei Italy 51 6.8k 0.8× 3.3k 0.7× 745 0.2× 791 0.2× 432 0.2× 224 9.4k
Yu‐ichi Goto Japan 47 7.7k 0.9× 3.3k 0.7× 290 0.1× 920 0.3× 567 0.2× 288 10.2k
Arthur P. Hays United States 61 3.9k 0.5× 862 0.2× 1.6k 0.4× 1.4k 0.4× 628 0.3× 170 10.3k
Gen Sobue Japan 82 12.4k 1.5× 532 0.1× 4.7k 1.3× 4.2k 1.2× 1.4k 0.6× 754 28.1k

Countries citing papers authored by Darryl C. De Vivo

Since Specialization
Citations

This map shows the geographic impact of Darryl C. De Vivo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darryl C. De Vivo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darryl C. De Vivo more than expected).

Fields of papers citing papers by Darryl C. De Vivo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darryl C. De Vivo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darryl C. De Vivo. The network helps show where Darryl C. De Vivo may publish in the future.

Co-authorship network of co-authors of Darryl C. De Vivo

This figure shows the co-authorship network connecting the top 25 collaborators of Darryl C. De Vivo. A scholar is included among the top collaborators of Darryl C. De Vivo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darryl C. De Vivo. Darryl C. De Vivo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Servais, Laurent, John Day, Darryl C. De Vivo, et al.. (2024). Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry. Journal of Neuromuscular Diseases. 11(2). 425–442. 27 indexed citations
2.
Schroth, Mary, J. Deans, Kapil Arya, et al.. (2024). Spinal Muscular Atrophy Update in Best Practices. Neurology Clinical Practice. 14(4). e200310–e200310. 9 indexed citations
3.
Tizzano, Eduardo F., Susana Quijano-Roy, Laurent Servais, et al.. (2024). Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec. European Journal of Paediatric Neurology. 53. 18–24.
4.
Coratti, Giorgia, Sally Dunaway Young, Darryl C. De Vivo, et al.. (2023). Measuring Fatigue and Fatigability in Spinal Muscular Atrophy (SMA): Challenges and Opportunities. Journal of Clinical Medicine. 12(10). 3458–3458. 17 indexed citations
5.
ALLEN, NEIL K., B. Eymard, Maryam Oskoui, et al.. (2023). VP278 The emerging spectrum of fetal acetylcholine receptor antibody-associated disorders (FARAD). Neuromuscular Disorders. 33. S179–S180. 2 indexed citations
6.
Vivo, Darryl C. De, et al.. (2023). Systemic Reduction of Glut1 Normalizes Retinal Dysfunction, Inflammation, and Oxidative Stress in the Retina of Spontaneous Type 2 Diabetic Mice. American Journal Of Pathology. 193(7). 927–938. 5 indexed citations
7.
Tayebi, Naeimeh, Kevin McCall, Kristin Engelstad, et al.. (2023). Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome. Annals of Clinical and Translational Neurology. 10(5). 787–801. 5 indexed citations
8.
Lee, Michelle M., Darryl C. De Vivo, Daniel Friedman, et al.. (2022). The clinical spectrum of SMA‐PME and in vitro normalization of its cellular ceramide profile. Annals of Clinical and Translational Neurology. 9(12). 1941–1952. 5 indexed citations
9.
Sharma, Rohit, Kristin Engelstad, Owen S. Skinner, et al.. (2021). Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity. Journal of Clinical Investigation. 131(2). 133 indexed citations
10.
Magrinelli, Francesca, Eoin Mulroy, Susanne A. Schneider, et al.. (2020). Criss-cross gait. Neurology. 95(11). 500–501. 7 indexed citations
11.
Finkel, Richard S., John Day, Darryl C. De Vivo, et al.. (2020). RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study Design. Journal of Neuromuscular Diseases. 7(2). 145–152. 26 indexed citations
12.
Servais, Laurent, John Day, Darryl C. De Vivo, et al.. (2020). Real-World Treatment Patterns and Outcomes in Patients with Spinal Muscular Atrophy Collected from the RESTORE Registry (2470). Neurology. 94(15_supplement).
13.
Montes, Jacqueline, Sally Dunaway Young, Elena Mazzone, et al.. (2018). Ambulatory function and fatigue in nusinersen-treated children with spinal muscular atrophy. (P2.322). Neurology. 90(15_supplement). 4 indexed citations
14.
Kirschner, Janbernd, Eugenio Mercuri, Richard S. Finkel, et al.. (2017). Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study. Neuropediatrics. 48.
15.
Glanzman, Allan M., Elena Mazzone, Sally Dunaway Young, et al.. (2017). Reliability of functional outcome measures in spinal muscular atrophy: Results from multi-centered, global, phase 3 clinical trials (S13.004). Neurology. 88(16_supplement).
16.
Sanctis, Roberto De, Giorgia Coratti, Amy Pasternak, et al.. (2016). Developmental milestones in type I spinal muscular atrophy. Neuromuscular Disorders. 26(11). 754–759. 90 indexed citations
17.
Finkel, Richard S., John Day, Claudia A. Chiriboga, et al.. (2014). Results of a Phase 2 Open-Label Study of ISIS-SMNRx in Patients with Infantile (Type 1) Spinal Muscular Atrophy (S6.003). Neurology. 82(10_supplement). 8 indexed citations
18.
Montes, Jacqueline, Samantha Kramer, Sally Dunaway Young, et al.. (2014). A Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy (SMA) Patients (S16.003). Neurology. 82(10_supplement). 1 indexed citations
19.
Glanzman, Allan M., Michael McDermott, Jacqueline Montes, et al.. (2011). Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatric Physical Therapy. 23(4). 322–326. 95 indexed citations
20.
Weimer, Louis H., Kristin Engelstad, Vanessa Battista, et al.. (2010). Autonomic Symptoms in Carriers of the m.3243A>G Mitochondrial DNA Mutation. Archives of Neurology. 67(8). 976–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lewis P. Rowland Breakdown of academic impact, for papers by Anders Oldfors Breakdown of academic impact, for papers by Michio Hirano Breakdown of academic impact, for papers by Filippo M. Santorelli Breakdown of academic impact, for papers by S. DiMauro Breakdown of academic impact, for papers by Gabriele Siciliano Breakdown of academic impact, for papers by Serenella Servidei Breakdown of academic impact, for papers by Yu‐ichi Goto Breakdown of academic impact, for papers by Arthur P. Hays Breakdown of academic impact, for papers by Gen Sobue
Rankless by CCL
2026